Kieran Breen

Dr Kieran Breen is Scientific Advisor to Parkinson's Europe, a role he has held since 2013, and previously served as Director of Research and Innovation at Parkinson's UK, where he led a £5.5m annual research portfolio and initiated an international consortium to develop a cloud-based patient database platform uniting academia, industry, regulators and data experts. He is Vice-Chair of the European Medicines Agency's Committee for Advanced Therapies (CAT), where he has led a cross-committee task force developing guidelines on patient registries and real-world evidence in ATMP clinical trial design. He was also a member of the EMA Patient and Consumer Working Party, focusing on the implementation of patient-reported outcome measures, and serves as an EU Horizon expert panellist on patient experience data (PED). With more than 30 years' experience spanning neuroscience research, medicines regulation and health innovation, Dr Breen has championed the use of patient experience data — from